Baringa Partners, the international and award-winning management consultancy, continues to expand its service offerings by opening a Pharmaceuticals & Lifesciences practice in London, and welcomes newly appointed partner Kate Moss.
It is evident that the Pharmaceuticals & Lifesciences Industries are undergoing tremendous change and embracing the opportunities technology and data can bring. Although there is ongoing pressure to deliver more and improved outcomes at lower cost, the pace of innovation and desire to translate new science into tangible and valuable solutions is increasing. Evolving the funding, regulation, delivery & access models will be important for the future and companies will want help in leveraging process, technology and customer insights while creating the future talent, skills & behaviours.
Over the last two decades Baringa has provided advisory services to other heavily regulated industries all undergoing significant innovation, delivery & policy challenges. This includes the Energy, Financial Services & Telecomms sectors where we have established a reputation for quality, expertise and client focus, from strategy through to delivery.
Our clients are keen to see us enhance our delivery into other science led industries as companies across sectors start to collaborate to address societal issues such as food shortages, health and climate change. Likewise, we have talented consultants who would like to focus their careers in helping Pharmaceutical & Lifesciences companies deliver challenging projects linked to improved global health outcomes. And our capabilities in technology, process, data analysis and AI, supply chain and customer and digital are all highly relevant to the challenges faced. In response to this, Baringa has created a dedicated Pharmaceuticals & Lifesciences practice and we are delighted that Kate Moss has joined us to lead our offering and capability.
Kate has 30 years of experience working with Pharmaceuticals & Lifesciences organisations as an employee and in an advisory capacity. She has supported clients with delivering complete transformation programmes and technology-driven change across the value chain.
Andrew Chittenden, Senior Partner, says, “We see there is appetite for a high quality, mid-sized, independent advisory practice that offers Pharmaceuticals & Lifesciences companies something different to what others offer. Baringa is renowned for deep industry expertise, implementable advice, and working collaboratively with clients to make change happen. We are delighted that Kate has chosen to join us.”
Kate Moss, Partner, says, “The Pharmaceuticals & Lifesciences companies have a positive record of always looking forward and embracing new ideas and the most challenging change. I am excited to have joined Baringa and delighted with the new capabilities we can bring to clients and the way our culture supports doing the right thing for our people, our clients and society.”
For enquiries please contact email@example.com.